In a pioneering study, researchers found that tumor-infiltrating T-cells significantly upregulate SLC6A8 (CrT), and global deficiency of CrT in CD8 T-cells prevented anti-tumor immune responses [25]. Here, SLC6A8 is linked to neoplasm.